141 related articles for article (PubMed ID: 3165865)
1. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients.
van der Weide M; Sizoo W; Nauta JJ; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Aug; 41(2):115-22. PubMed ID: 3165865
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
Tricot G; Vlietinck R; Boogaerts MA; Hendrickx B; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 May; 60(1):19-32. PubMed ID: 3859319
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes: analysis of morphological features related to the FAB-classification.
van der Weide M; Sizoo W; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Jul; 41(1):58-61. PubMed ID: 2456946
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
Rubio-Felix D; Giraldo P; Franco E; Gimeno J; Giralt M
Hematol Oncol; 1995; 13(3):139-52. PubMed ID: 7622144
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of myelodysplastic syndromes--a simplified 3-D scoring system.
Goasguen JE; Garand R; Bizet M; Bremond JL; Gardais J; Callat MP; Accard F; Chaperon J
Leuk Res; 1990; 14(3):255-62. PubMed ID: 2319806
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
Jacobs RH; Cornbleet MA; Vardiman JW; Larson RA; Le Beau MM; Rowley JD
Blood; 1986 Jun; 67(6):1765-72. PubMed ID: 3708160
[TBL] [Abstract][Full Text] [Related]
8. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia.
Weisdorf DJ; Oken MM; Johnson GJ; Rydell RE
Br J Haematol; 1983 Dec; 55(4):691-700. PubMed ID: 6608368
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
[TBL] [Abstract][Full Text] [Related]
10. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
[TBL] [Abstract][Full Text] [Related]
12. Primary myelodysplastic syndrome in children: the clinical experience in 33 cases.
Tuncer MA; Pagliuca A; Hicsonmez G; Yetgin S; Ozsoylu S; Mufti GJ
Br J Haematol; 1992 Oct; 82(2):347-53. PubMed ID: 1419817
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
Foucar K; Langdon RM; Armitage JO; Olson DB; Carroll TJ
Cancer; 1985 Aug; 56(3):553-61. PubMed ID: 3891071
[TBL] [Abstract][Full Text] [Related]
14. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome: a study of prognostic factors.
Lin JS; Lin CK; Liu SM; Chen LY; Wang SY
J Formos Med Assoc; 1991 Mar; 90(3):232-9. PubMed ID: 1677397
[TBL] [Abstract][Full Text] [Related]
17. Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases.
Kerkhofs H; Hermans J; Haak HL; Leeksma CH
Br J Haematol; 1987 Jan; 65(1):73-81. PubMed ID: 3814528
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.
Kyriakou D; Eliopoulos AG; Alexandrakis M; Kalokyri I; Eliopoulos GD
Haematologia (Budap); 1996; 28(1):1-7. PubMed ID: 9283897
[TBL] [Abstract][Full Text] [Related]
19. A study of the haematologic spectrum of myelodysplastic syndrome.
Kini J; Khadilkar UN; Dayal JP
Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
[TBL] [Abstract][Full Text] [Related]
20. Proliferative indices, cytogenetics, immunophenotye and other prognostic parameters in myelodysplastic syndromes.
Varma N; Varma S
Indian J Pathol Microbiol; 2008; 51(1):97-101. PubMed ID: 18417875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]